Pubblicazioni

Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS

2023 - FRONTIERS IN ONCOLOGY

Masucci, Chiara; Pepe, Sara; La Rocca, Ursula; Zullino, Veronica; De Propris, Maria Stefania; Barberi, Walter; Iori, Anna Paola; Martelli, Sabina; Ruberto, Franco; Martelli, Maurizio; Di Rocco, Alice

Case Report: Severe cutaneous adverse event associated with checkpoint inhibition in the setting of CAR T-cell therapy: beyond CRS

2023 - FRONTIERS IN ONCOLOGY

Masucci, C; Pepe, S; La Rocca, U; Zullino, V; De Propris, Ms; Barberi, W; Iori, Ap; Martelli, S; Ruberto, F; Martelli, M; Di Rocco, A

Benefit and danger from immunotherapy in myasthenia gravis

2021 - NEUROLOGICAL SCIENCES

Rodolico, C.; Nicocia, G.; Damato, V.; Antonini, G.; Liguori, R.; Evoli, A.

Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events

2020 - EUROPEAN JOURNAL OF CANCER

Cortellini, A.; Bersanelli, M.; Santini, D.; Buti, S.; Tiseo, M.; Cannita, K.; Perrone, F.; Giusti, R.; De Tursi, M.; Zoratto, F.; Marconcini, R.; Russano, M.; Zeppola, T.; Anesi, C.; Filetti, M.; Marchetti, P.; Botticelli, A.; Gelibter, A.; De Galitiis, F.; Vitale, M. G.; Rastelli, F.; Tudini, M.; Silva, R. R.; Atzori, F.; Chiari, R.; Ricciuti, B.; De Giglio, A.; Migliorino, M. R.; Mallardo, D.; Vanella, V.; Mosillo, C.; Bracarda, S.; Rinaldi, S.; Berardi, R.; Natoli, C.; Ficorella, C.; Porzio, G.; Ascierto, P. A.

Immunological backbone of uveal melanoma: is there a rationale for immunotherapy?

2019 - CANCERS

Rossi, Ernesto; Schinzari, Giovanni; Zizzari, Ilaria Grazia; Maiorano, Brigida Anna; Pagliara, Monica Maria; Sammarco, Maria Grazia; Fiorentino, Vincenzo; Petrone, Gianluigi; Cassano, Alessandra; Rindi, Guido; Bria, Emilio; Blasi, Maria Antonietta; Nuti, Marianna; Tortora, Giampaolo

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity

2019 - JOURNAL FOR IMMUNOTHERAPY OF CANCER

Minniti, G.; Anzellini, D.; Reverberi, C.; Cappellini, G. C. A.; Marchetti, L.; Bianciardi, F.; Bozzao, A.; Osti, M.; Gentile, P. C.; Esposito, V.

Current status of immunotherapy for non-small-cell lung cancer

2016 - TUMORI

Imbimbo, Martina; Lo Russo, Giuseppe; Blackhall, Fiona